‘We’re not ready’: US lags on pandemic preparedness after Covid, experts say Experts say slashed funding and growing misinformation are some of the greatest challenges facing public health The Guardian - US · May 17
WHO declares Ebola outbreak in DRC a health emergency 'of international concern' An Ebola outbreak in the Democratic Republic of Congo has killed more than 80 as authorities warned there was no vaccine for the strain in a crisis that the World Health Organization declared an international health emergency on Sunday. Radio France Internationale · May 17
Meningitis outbreak: calls grow for wider vaccine rollout after Oxfordshire teen dies The heartbreaking loss of a student in Oxfordshire due to meningitis has sparked renewed advocacy for comprehensive vaccination programs for teens across the UK. With one case of Meningitis B confirmed and further inquiries underway, health experts are rallying for updated immunizations. The Times of India · May 16
Trump's Top Hantavirus Official Is a Penile Implant Specialist Who Hosted a Conspiracy Theory Podcast Dr. Brian Christine, a former urologist, now leads US public health efforts despite a controversial past involving conspiracy theories and scepticism towards Covid vaccines. International Business Times UK · May 16
Charity chief calls for wider rollout of meningitis vaccine A college student died in Oxfordshire after contracting the disease. Evening Standard · May 16
BioNTech Maps Oncology Push, $1B Buyback and Manufacturing Cuts at AGM BioNTech (NASDAQ:BNTX) used its virtual annual general meeting to outline a transition year marked by leadership changes, continued investment in oncology, a planned share repurchase program and a restructuring of its manufacturing network. Chairman of the Supervisory Board Helmut Jeggle said the 2 MarketBeat · May 15
Hantavirus outbreak: Scientists ran out of funds while developing a vaccine, report says A Hantavirus outbreak linked to the MV Hondius cruise ship has tragically claimed three lives this year, with 11 cases reported. While infections are rare, this outbreak highlights the urgent need for a vaccine, with research stalled by funding issues. International efforts are underway to manage the current situation, focusing… The Times of India · May 14
Hantavirus scientists were close to vaccine but ran out of money Scientists in Chile developed antibodies that successfully neutralised the deadly Andes hantavirus in lab and animal studies, raising hopes for a treatment against the rare virus that can spread between people. But the project stalled before human trials due to lack of funding and the Covid-19 pandemic. The Economic Times · May 14
Valneva Q1 Earnings Call Highlights Valneva (NASDAQ:VALN) reported lower first-quarter revenue and a wider loss for 2026, while management said the company is focused on conserving cash as it awaits the next regulatory steps for its Lyme disease vaccine candidate being developed with Pfizer. Chief Executive Officer Thomas Lingelbach MarketBeat · May 13
Staged claims and Israeli hoaxes: Debunking viral conspiracy theories about hantavirus Misinformation about hantavirus has run rampant on social media, with online users reviving viral COVID-19 theories to spread fake news about the outbreak. Euronews · May 13
Is there a hantavirus vaccine? Scientists race to develop one for new strain A deadly hantavirus outbreak on a cruise ship has raised fears over emerging viruses with no cure or vaccine. The UK government had already commissioned researchers to develop what could become the world’s first hantavirus vaccine Euronews · May 13
Urgent care clinics, medicines and vaccines: what the budget means for Australians’ health Health was at the heart of last year’s budget. Last night, tax and housing took centre stage, and there were few surprises in health. The Conversation · May 13
Capricor Therapeutics Q1 Earnings Call Highlights Capricor Therapeutics (NASDAQ:CAPR) said its Duchenne muscular dystrophy therapy candidate deramiocel remains under active FDA review, while the company is preparing to commercialize the product itself amid a legal dispute with distribution partner NS Pharma and parent company Nippon Shinyaku. On t MarketBeat · May 12
The White House told RFK Jr to tone down his statements questioning vaccines. That hasn’t stopped him behind the scenes The reported review concerns Kennedy’s long-held skepticism of mainstream vaccine science The Independent UK · May 12
International Business Times UK · May 11 Is There A Cure For Hantavirus Infection? 'Breathed In' Virus Kills 38% Of Patients, Scientists Race For Vaccine A deadly cruise ship outbreak of the Andes strain has revived global interest in a long‑delayed hantavirus cure, as scientists warn that early hospital care can make the difference between survival and a 38% fatality risk.
AAP · May 11 Free meningococcal jabs for some but 'lottery' persists A fourth Australian jurisdiction will provide free jabs to some teens for a rare but life-threatening disease as the push for national coverage marches on.
The Guardian - UK · May 10 The Guardian view on the WHO pandemic treaty: the west’s fantasy negotiations have put the world at risk Editorial: After five years of deliberation the global south has forced the question that defined the Covid crisis: who will get the vaccines?
The Guardian - US · May 9 ‘The FDA is a complete mess’: Trump makes fate of agency chief unclear as public trust plummets Food and Drug Administration commissioner’s decisions have hurt staff morale and put his job in crosshairs
Salon · May 7 Trump's Silicon Valley bet on science Jim O'Neill, a longevity enthusiast and vaccine skeptic, is Trump's pick to head the National Science Foundation
Reason · May 7 Trump's Health Bureaucrats Are Undermining Confidence in Vaccines From spiked CDC reports to blocked FDA studies, officials sidelined evidence showing vaccines are safe and effective.
The Independent UK · May 7 FDA's new playbook: Lots of media announcements but not much rulemaking Health Secretary Robert F. Kennedy Jr. and other health officials have repeatedly announced major changes before any new rules have been drafted
The Guardian - US · May 7 ‘People should be talking about it’: moves to curtail vaccine information obscures important science, doctors say Quashed studies, halted publications and canceled research threaten damage to public health, critics say
International Business Times · May 6 HHS Studies That Found Covid, Shingles Vaccines Safe And Effective Pulled From Scientific Journals The Food and Drug Administration (FDA) has withdrawn studies that suggested COVID-19 and shingles vaccines were safe and effective.
The Independent UK · May 6 Trump’s third surgeon general pick is deleting old posts critical of president’s agenda and fitness Dr Nicole Saphier, a radiologist, author and Fox News contributor, scrubs X account of posts questioning administration’s handling of issues related to autism and vaccines
Latin Times · May 6 Experts Criticize F.D.A. Move to Withhold Studies on Vaccine Safety: 'A Pretty Active Act of Sabotage' Blocked publications on COVID and shingles vaccines come amid broader changes to federal policy under Health Secretary Robert F. Kennedy Jr., a longtime vaccine critic